Article Text

Download PDFPDF
Recurrent multiple cranial nerve palsies: a distinctive syndrome of cranial polyneuropathy
  1. John C. Steele2,
  2. Aramasi Vasuvat
  1. Prasat Neurological Hospital and Research Institute, Bangkok, Thailand

    Abstract

    This report of 14 Thai patients describes the clinical features of a symptom-complex we have termed recurrent multiple cranial nerve palsies. While the disorder is common in South Eastern Asia, patients suffering similar symptoms have been seen in Europe and America. Characteristically, a long prodromal headache precedes the abrupt onset of multiple cranial nerve palsies affecting predominantly, although not exclusively, the oculomotor and facial nerves. Symptoms are self-limited and steroid therapy hastens recovery in most cases. Recurrence after many months or years is not uncommon and different cranial nerves may then be affected. Wider neurological involvement seems not to occur. Although the erythrocyte sedimentation rate is frequently elevated there is no other evidence of co-existing systemic disease. The single necropsy study thus far reported indicates that the pathogenesis of the syndrome is granulomatous inflammation of the meninges (dura), adjacent to, and involving the perineurium of cranial nerves. It is uncertain whether this inflammation is a response to a single agent, as yet unidentified, or a focal and selective hypersensitivity reaction of connective tissue to a number of different factors. As a clinical entity the syndrome is distinctive, international, and deserving of wide recognition.

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • 2 Address for reprints: Department of Neurology, The Hospital for Sick Children, Toronto 101, Canada.

    • 1 Presented at the Ninth International Congress of Neurology, New York, September 1969.